Characterization and Evaluation of Diagnostic Biomarkers for Tuberculosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

270 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-06-30

Study Completion Date

2014-05-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There was no sensitive and specific biomarker for tuberculosis infection, disease progression and predicting the prognosis of treatment. Therefore, the investigators aimed to investigate and evaluate the newer biomarker for the diagnosis of TB infection. To investigate the new biomarker for TB infection, the investigators will recruit the participants including active TB patients, healthy household contacts, healthy community control.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Retrospective Cohort Study to Develop Markers for TB Severity and Treatment Progress

NCT05477966

Pulmonary Tuberculoses Tuberculosis, Pulmonary

UNKNOWN

Lung Innate Immunity and Microbiome After Tuberculosis Exposure

NCT06526689

Tuberculosis Latent Tuberculosis

RECRUITING

LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea

NCT06946784

Tuberculosis Post Tuberculosis

RECRUITING

Improving the Diagnostic of Tuberculosis

NCT02861768

Tuberculosis

COMPLETED NA

Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis

NCT04930978

COVID-19 Respiratory Infection Pulmonary Tuberculoses

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Active Tuberculosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

active tuberculosis

active TB patients : diagnosed with TB through microbiologic examination

No interventions assigned to this group

healthy control

healthy control : no evidence of respiratory disease, no respiratory symptoms, and no history of close contact of active pulmonary TB patients

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* active TB patients : diagnosed with active TB through the microbiologic examination, imaging findings
* healthy control : no history of TB treatment, no respiratory symptoms, no evidence of active infectious disease including TB on chest X-ray, no history of close contacts of active pulmonary TB patients